Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05492188

Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI

Targeted Spinal Cord Plasticity for Alleviating SCI-related Neuropathic Pain

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the second part of the study is to examine the effect of reflex training in the leg to decrease neuropathic pain. For this, the researchers are recruiting 15 individuals with neuropathic pain due to spinal cord injury to participate in the reflex training procedure. The study involves approximately 50 visits with a total study duration of about 6.5 months (3 months for baseline and training phases followed by 1 month and 3 month follow-up visits).

Detailed description

As part of the larger study of the relationship between reflexes in the leg and the presence of neuropathic pain, the researchers are also recruiting 30 individuals with spinal cord injury (SCI) total, 15 individuals with neuropathic pain due to SCI and 15 individuals without neuropathic pain. For this portion of the study, there are 2 visits. The first visit will examine cutaneous reflexes in the leg. During the second visit, the study team will assess sensation in the leg and administer questionnaires about pain, functioning, and quality of life. This portion of the study does not involve an intervention. The study will then recruit 15 individuals who will participate in reflex training, as described in the brief summary.

Conditions

Interventions

TypeNameDescription
BEHAVIORALOperant Conditioning of Cutaneous ReflexesThis is a training intervention in which people with a spinal cord injury are trained to change (increase or decrease) the activity of a certain spinal reflex. By changing this reflex, it is hypothesized that individuals can reduce pain due to spinal cord injury.

Timeline

Start date
2023-03-27
Primary completion
2026-10-01
Completion
2026-10-01
First posted
2022-08-08
Last updated
2025-10-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05492188. Inclusion in this directory is not an endorsement.